Featured News
Press Release
Bipartisan Legislation to Streamline Dementia Care Reintroduced in Senate
Comprehensive Care for Alzheimer’s Act Washington, D.C., March 3, 2023 — The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the bipartisan Comprehensive Care...
All News
AIM Blog
Recognizing AIM’s January Advocate of the Month: Bertha Bullen
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer's Association Welcomes U.S. FDA Approval of Lecanemab
Association Renews Urgent Call for CMS to Cover FDA-Approved Alzheimer’s Treatments CHICAGO, January 6, 2023 — The Alzheimer’s Association enthusiastically...
AIM Blog
A Look Back on the 117th Congress’ Actions to Address Alzheimer’s and Dementia
Thanks to our hardworking advocates and congressional champions, critical bipartisan policy priorities to address Alzheimer’s and dementia across the nation...
Press Release
Critical Alzheimer’s and Dementia Priorities Signed Into Law
Washington, D.C., December 29, 2022 – The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the...
Press Release
Congress Prioritizes Addressing Alzheimer’s and Dementia
Key provisions of the ENACT Act, language to strengthen FDA accelerated approval pathway, a $226 million increase for Alzheimer’s and...
Press Release
Alzheimer’s Association Calls on CMS to Reverse Its Decision to Severely Limit Access to FDA-Approved Alzheimer’s Disease Treatments
Association Files Formal Request for Reconsideration of National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of...